Lynx Suprapubic Mid-Urethral Sling System is designed to maneuver through challenging tissue with a smoother association mechanism in the suprapubic pathway.

Paired with clinically supported Advantage™ optical blue mesh, Lynx Ultra is intended to facilitate suprapubic device passage with a tapered dilator designed for smooth transition from loop to mesh with minimal tissue disruption.

Lynx Suprapubic Mid-urethral Sling Systems is ofered in original clear mesh, as well as AdvantageTM blue mesh, providing improved visibility and used in over 1 Million Advantage products.* A smooth, de-tanged suburethral portion designed to maintain its integrity during tensioning and potentially reduce irritation to the urethral wall

The Gynecare TVT was the most cited sling kit; the second most cited was the SPARC. This review provides a summary of the studies that have examined positive and negative outcomes of the retropubic tension-free suburethral sling procedure using various sling kits.

2008年4月26日 · The Lynx® midurethral sling system shows high subjective and objective success rates for the treatment of USI at 1 year with low rates of intraoperative and postoperative complications.

The three tension-free urethral suspension techniques have similar efficacy, all of them are safe and effective procedures for the treatment of female SUI. Compared with TVT, TVT-O and TOT are simpler, less invasive and have fewer complications.

2006年4月1日 · The Gynecare TVT sling kit was examined in the majority of studies and was also reported in 2007 as being the most widely used retropubic sling system. 20 There are 20 reports on the Gynecare...

Since Ulmsten and Petros's original description of the tension-free vaginal tape (TVT) procedure in 1995, the midurethral sling (MUS) has become first-line therapy for correction of female stress urinary incontinence (SUI). Cure rates are high for TVT and the recent tension-free trans-... Download Free PDF View PDF

Urethral closure pressure <14 cm H 2 O was the identifiable risk for objective failure. Objective cure rates were 96% (46 patients) for the TVT and 94% (45 patients) for the Lynx (p=.12), suggesting that some subjective failure was likely due to de novo bladder overactivity.

2015年7月22日 · Results of this literature review revealed 38 peer-reviewed articles published between 1995 and 2014 that examined side effects, treatment outcomes, and patient acceptability of eight retropubic sling kits: Advantage and Lynx (Boston Scientific), Align (Bard), Desara (Caldera), Gynecare TVT (Ethicon), SPARC and RetroArc Retropubic Sling System ...